Download PDF

Other users also viewed these articles

Do patients with axial spondyloarthritis with active disease suffer from greater disease burden and work impairment? Results from the International Map of Axial Spondyloarthritis (IMAS) Marco Garrido-Cumbrera; Denis Poddubnyy; Fernando Sommerfleck; Christine Bundy; Souzi Makri; José Correa-Fernández; Shashank Akerkar; Jo Lowe; Elie Karam; Victoria Navarro-Compán;
Reumatol Clin. 2024;20:547-54
Effectiveness of a checklist for the control of the disease activity in patients with axial spondyloarthritis Raquel Almodóvar; Elia Pérez-Fernández; Marta Valero; Virginia Villaverde; Laura González; Beatriz Joven Ibáñez; Eva Tomero Muriel; Alejandro Prada Ojeda; M.a Teresa Navio; Laura Cebrián Méndez; Leticia Lojo; Ramón Mazzucchelli; Pedro Zarco Montejo;
Reumatol Clin. 2025;21:
TNF¿-inhibitors cycling with golimumab as second drug in inflammatory arthritis patients: Data from the multicenter GO-REAL registry Carolina Ayelen Isnardi; Emma Estela Civit De Garignani; Agustín García Ciccarelli; Jimena Sanchez Alcover; Ingrid Strusberg; Marcos Baravalle; Sol Castaños; Liliana Morales; Matias Palombo; Eduardo Albiero; Carla Gobbi; Rodrigo Garcia Salinas; Sebastian Magri; Edson Velozo; Enrique R. Soriano; Alfredo Vargas Caselles; Luis Carlos Palomino Romero; Sergio Paira; Romina Calvo; Alberto Ortiz; María Julieta Gamba; Rodolfo Perez Alamino; Hernan Maldonado Ficco; Gustavo Citera;
Reumatol Clin. 2024;20:539-46